AIRR - ANZCA Institutional Research Repository
Skip navigation
Please use this identifier to cite or link to this item: https://hdl.handle.net/11055/577
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDeer TRen_US
dc.contributor.authorSkaribas Ien_US
dc.contributor.authorMcJunkin Ten_US
dc.contributor.authorNelson Cen_US
dc.contributor.authorSalmon Jen_US
dc.contributor.authorDarnule Aen_US
dc.contributor.authorBraswell JJen_US
dc.contributor.authorRusso Men_US
dc.contributor.authorGomezese OFen_US
dc.date2016-02-18-
dc.date.accessioned2018-06-15T01:15:21Z-
dc.date.available2018-06-15T01:15:21Z-
dc.date.issued2016-02-18-
dc.identifier.citation19(2):179-187en_US
dc.identifier.urihttp://hdl.handle.net/11055/577-
dc.description.abstractOBJECTIVE: This longitudinal, clinical outcome study was a multicenter, prospective, observational, registry with a 24-month assessment of patients implanted with spinal cord stimulation (SCS) systems for the management of chronic pain of the trunk and/or limbs. METHODS: On informed consent and institutional review board approval, 614 patients from 39 sites were enrolled within 30 days following permanent SCS system implantation. Medication usage, patient-reported pain relief (PRP), categorical ratings of pain relief, pain disability index scores (PDI), quality of life (QoL), and patient satisfaction were assessed at enrollment, 3-, 6-, 12-, 18-, and 24-month postimplant. Device-related adverse events (AEs) were recorded and reported. RESULTS: Across all visits, statistically significant improvements were reported on all outcome measures. Mean PRP was 58.5% (± 26.4) at 3 months, 56.8% (± 29.2) at 6 months, 57.7% (± 28.9) at 12 months, 55.6% (± 29.8) at 18 months, and 56.3% (± 30.3) at 24 months. More than 65% of patients at any visit reported a PRP ≥ 50%. Mean PDI scores reduced from 46.9 points at baseline to 32.7, 31.8, 31.5, 32.1, 32.1 points at 3, 6, 12, 18, and 24 months (p ≤ 0.0001), respectively. Greater than 76% of patients at any visit were satisfied with their therapy. The majority of patients categorized pain relief as excellent or good on a 5-item scale and reported overall QoL as greatly improved or improved on a 5-item scale. An average of 88% of patients stopped, decreased, or did not change dose of narcotics/opioids. The most common AE was diminished or loss of pain relief in 11.4% of enrolled patients. CONCLUSIONS: Most patients experienced substantial pain relief and a significant improvement in all outcome measures. These results further support the safety, efficacy, and sustainability of SCS in clinical practice.en_US
dc.subjectChronic Painen_US
dc.subjectclinical trialen_US
dc.subjectregistryen_US
dc.subjectSpinal Cord Stimulationen_US
dc.titleResults From the Partnership for Advancement in Neuromodulation Registry: A 24-Month Follow-Upen_US
dc.typeJournal Articleen_US
dc.type.contentTexten_US
dc.identifier.journaltitleNeuromodulation: Technology at the Neural Interfaceen_US
dc.identifier.doi10.1111/ner.12378en_US
dc.description.affiliatesCenter for Pain Relief, Charleston, WV, USAen_US
dc.description.affiliatesGreater Houston Pain Consultants, U.S. Anesthesia Partners, Houston, TX, USAen_US
dc.description.affiliatesArizona Pain Specialists, Scottsdale, AZ, USAen_US
dc.description.affiliatesBluegrass Pain Consultants, Louisville, KY, USAen_US
dc.description.affiliatesPainCare Network, Perth Western, Australiaen_US
dc.description.affiliatesSpine Team Texas, Southlake, TX, USAen_US
dc.description.affiliatesThe Spine Diagnostic and Pain Treatment Center, Baton Rouge, LA, USAen_US
dc.description.affiliatesHunter Pain Clinic, Newcastle, NSW, Australiaen_US
dc.description.affiliatesFundacion Cardiovascular de Colombia, Bucaramanga Santander, Colombiaen_US
dc.description.pubmedurihttps://www.ncbi.nlm.nih.gov/pubmed/26890015en_US
dc.type.studyortrialProspective Cohort Studyen_US
dc.ispartof.anzcaresearchfoundationYesen_US
local.message.claim2023-05-02T11:41:30.644+1000|||rp00166|||submit_approve|||dc_contributor_author|||None*
dc.type.specialtyAnaesthesiaen_US
item.fulltextWith Fulltext-
item.grantfulltextreserved-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Scholarly and Clinical
Files in This Item:
File Description SizeFormat 
Results From the Partnership for Advancement in Neuromodulation Registry (ID 54778).pdf
  Restricted Access
430.78 kBAdobe PDFView/Open    Request a copy
Show simple item record

Page view(s)

28
checked on Mar 28, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.